Literature DB >> 3570167

Hepatitis B virus replication in acute hepatitis B, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfection.

J Genesca, R Jardi, M Buti, L Vives, S Prat, J I Esteban, R Esteban, J Guardia.   

Abstract

To evaluate the effect of hepatitis delta virus on the level of replication of hepatitis B virus and to assess the clinical significance that such an effect might have on the final outcome of the infection, the serological profile of hepatitis B virus DNA was investigated in 153 patients with acute or chronic hepatitis B virus infection with or without associated delta infection. Serum hepatitis B virus DNA was detected in 57% of patients with acute hepatitis B, 67% of those with acute hepatitis B virus-hepatitis delta virus coinfection and 25% of HBsAg carriers with hepatitis delta virus superinfection during the first week after the onset of symptoms. Patients with acute hepatitis B and those with acute hepatitis B virus-hepatitis delta virus coinfection did not differ significantly with respect to the serological profile of hepatitis B virus DNA and final clinical outcome. Within the group of HBsAg carriers with hepatitis delta virus superinfection, all patients who were initially negative for hepatitis B virus DNA developed chronic hepatitis delta virus infection, whereas 3 of the 4 patients with active hepatitis B virus infection at the time of superinfection showed transient inhibition of hepatitis B virus replication followed by termination of hepatitis delta virus infection in two patients. Therefore, although delta virus may inhibit the replication of hepatitis B virus among chronic HBsAg carriers, this effect is not readily apparent among patients with hepatitis B virus-hepatitis delta virus coinfection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570167     DOI: 10.1002/hep.1840070325

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  A study on hepatitis D virus infection in liver tissues of patients with hepatitis B in China.

Authors:  L J Hao; L Li; Y Y Zhang; P H Song
Journal:  J Tongji Med Univ       Date:  1990

2.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Authors:  Lauren M Kucirka; Homayoon Farzadegan; Jordan J Feld; Shruti H Mehta; Mark Winters; Jeffrey S Glenn; Gregory D Kirk; Dorry L Segev; Kenrad E Nelson; Morgan Marks; Theo Heller; Elizabeth T Golub
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

3.  Correlation between hepatitis B viremia and the clinical and histological activity of chronic delta hepatitis.

Authors:  J L Lozano; J Crespo; F de la Cruz; F Casafont; M J Lopez-Arias; L Martín-Ramos; F Pons-Romero
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

4.  Evaluation of enzyme immunoassay for hepatitis B virus DNA based on anti-double-stranded DNA.

Authors:  F Garcia; F Garcia; M C Bernal; A Leyva; G Piedrola; M C Maroto
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Cloned hepatitis delta virus cDNA is infectious in the chimpanzee.

Authors:  C Sureau; J Taylor; M Chao; J W Eichberg; R E Lanford
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B.

Authors:  N C Tassopoulos; M C Kuhns; M G Koutelou; A L McNamara; A Todoulos
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

7.  Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation.

Authors:  M R Lucey; D M Graham; P Martin; A Di Bisceglie; S Rosenthal; J G Waggoner; R M Merion; D A Campbell; T T Nostrant; H D Appelman
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.